Skip to main content
. 2021 Nov 22;12:6783. doi: 10.1038/s41467-021-27032-x

Fig. 6. A model of the transition of human MLKL from a dormant form to necroptotic effector.

Fig. 6

Human MLKL resides in a dormant state stably-complexed to RIPK3 in the cytoplasm via the bidentate interaction between MLKL and RIPK3 C-lobes. Following receipt of a necroptotic stimulus, RIPK3:MLKL complexes are recruited to the necrosome where RIPK3-mediated phosphorylation promotes MLKL structural interconversion, dissociation from the necrosome, and oligomerization47. Mutational perturbation of the MLKL:RIPK3 interaction prevents their stable association and recruitment to the necrosome, identifying formation of stable MLKL:RIPK3 complexes as a crucial checkpoint in the necroptotic pathway. Recruitment to the necrosome allows engagement of chaperone- and Golgi/microtubule/actin-mediated pathways to facilitate MLKL translocation to the plasma membrane32,56,57. Upon reaching a threshold level at the plasma membrane, MLKL can permeabilize membranes to cause cell death and damage-associated molecular pattern (DAMP) release. The skull and crossbones image (Mycomorphbox_Deadly.png; by Sven Manguard) was used under a Creative Commons Attribution-Share Alike 4.0 license.